Eukles Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-514
| Closed | -$63.3K | – | 226 |
|
|
2024
Q4 | $63.3K | Sell |
514
-39
| -7% | -$4.8K | 0.03% | 103 |
|
|
2024
Q3 | $61.6K | Sell |
553
-64
| -10% | -$7.13K | 0.02% | 104 |
|
|
2024
Q2 | $65.9K | Sell |
617
-79
| -11% | -$8.43K | 0.03% | 102 |
|
|
2024
Q1 | $83.8K | Sell |
696
-1,484
| -68% | -$179K | 0.04% | 98 |
|
|
2023
Q4 | $268K | Sell |
2,180
-144
| -6% | -$17.7K | 0.13% | 96 |
|
|
2023
Q3 | $301K | Hold |
2,324
| – | – | 0.16% | 91 |
|
|
2023
Q2 | $288K | Hold |
2,324
| – | – | 0.15% | 88 |
|
|
2023
Q1 | $340K | Buy |
2,324
+13
| +0.6% | +$1.9K | 0.18% | 85 |
|
|
2022
Q4 | $368K | Hold |
2,311
| – | – | 0.21% | 80 |
|
|
2022
Q3 | $308K | Buy |
2,311
+148
| +7% | +$19.7K | 0.2% | 80 |
|
|
2022
Q2 | $337K | Buy |
2,163
+1
| +0% | +$156 | 0.21% | 84 |
|
|
2022
Q1 | $337K | Sell |
2,162
-82
| -4% | -$12.8K | 0.18% | 85 |
|
|
2021
Q4 | $286K | Sell |
2,244
-223
| -9% | -$28.4K | 0.14% | 92 |
|
|
2021
Q3 | $321K | Buy |
2,467
+427
| +21% | +$55.6K | 0.18% | 87 |
|
|
2021
Q2 | $362K | Buy |
2,040
+244
| +14% | +$43.3K | 0.2% | 79 |
|
|
2021
Q1 | $295K | Buy |
1,796
+197
| +12% | +$32.4K | 0.19% | 81 |
|
|
2020
Q4 | $264K | Sell |
1,599
-148
| -8% | -$24.4K | 0.18% | 79 |
|
|
2020
Q3 | $249K | Buy |
1,747
+31
| +2% | +$4.42K | 0.19% | 80 |
|
|
2020
Q2 | $189K | Hold |
1,716
| – | – | 0.16% | 85 |
|
|
2020
Q1 | $171K | Buy |
1,716
+872
| +103% | +$86.9K | 0.18% | 83 |
|
|
2019
Q4 | $126K | Hold |
844
| – | – | 0.1% | 97 |
|
|
2019
Q3 | $108K | Hold |
844
| – | – | 0.09% | 98 |
|
|
2019
Q2 | $120K | Buy |
844
+19
| +2% | +$2.7K | 0.1% | 97 |
|
|
2019
Q1 | $118K | Hold |
825
| – | – | 0.11% | 94 |
|
|
2018
Q4 | $102K | Buy |
+825
| New | +$102K | 0.11% | 89 |
|